Pfizer BioNTech’s new corona vaccine, Fosun, approved for clinical trials in the mainland-20201115-China-Ming Pao News Network


  1. Pfizer BioNTech’s New Fosun Corona Vaccine Approved for Clinical Trials in Mainland China-20201115-ChinaMing Pao news network
  2. Fosun Pharma (02196.HK) spin-off Gland Pharma final price 1,500 rupees per shareAsdaq financial network
  3. Shanghai Fosun Pharma said its subsidiary was cleared to conduct vaccine clinical trials of foreign pharmaceutical companies – RTHKRadio Hong Kong
  4. New corona vaccine from subsidiary Fosun Pharma (02196.HK) gains clinical trial approvalAsdaq financial network
  5. View the full report on Google News
Source link